Transaction #31551 · Form 4 · 0001178913-26-004715
RedHill Biopharma Ltd. · Exercise / conversion · American Depository Shares
RedHill Biopharma Ltd. · Transacted October 1, 2026 · Filed October 6, 2026
What does this filing report?
An SEC Form 4 filing for RedHill Biopharma Ltd. records an exercise / conversion involving American Depository Shares on October 1, 2026. The reported quantity was 27,560,000. The filing date is October 6, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- RedHill Biopharma Ltd.
- Company CIK
- 0001553846
- Security type
- Derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 27,560,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 131,690,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 6, 2026, 7:00 AM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Raday Gilead ↗
Chief Operating Officer
CIK 0002113137
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Ordinary Shares
- Underlying quantity
- 27,560,000
- Conversion / exercise price
- Not reported
- Exercise date
- Not reported
- Expiration date
- Not reported
Filing footnotes & remarks
- F1
- The reporting person sold 1,431 American Depository Shares ("ADS"), of RedHill Biopharma Ltd. (the "Issuer"), each ADS represents 10,000 ordinary shares, which have no par value effective August 7, 2026, solely to satisfy tax withholding obligations incurred upon the vesting of an aggregate of 4,187 Restricted Share Units ("RSU") granted to him on March 26, 2025, and January 23, 2026. Such transaction was effected by the trustee appointed in accordance with the regulations set by the Israeli Tax Authority pursuant to a sell to cover policy and does not represent a discretionary trade by the reporting person.
- F2
- The price reported in Table 1 Column 4 is $0.465 per ADS, which would be equivalent to $0.0000465 per ordinary share.
- F3
- Each ADS is convertible at any time, at the holder's election, for no consideration and has no expiration date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.